Also, NOTCH1-induced upregulation of CD44 was essential for NOTCH1-dependent human T-ALL pathogenesis since treatment with anti-CD44 antibodies reduced BM engraftment of NICD+ preleukemic cells, and eradicated disease progression of established T-ALL patient-derived xenografts [92]. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.